About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

KEGG DRUG

DrugBank

Drug (Description in trials)

KEGG GENES

KEGG PATHWAY

Disease ID

1

[2] MTNR1A,
MTNR1B 💬

[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬

[16] 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202 💬

Disease ID	Name
2	Amyotrophic lateral sclerosis
6	Parkinson disease
8	Huntington disease
13	Multiple sclerosis
37	Generalised pustular psoriasis
46	Malignant rheumatoid arthritis
49	Systemic lupus erythematosus
72	Pituitary ADH secretion disorder
78	Hypopituitarism
86	Pulmonary arterial hypertension
90	Retinitis pigmentosa
96	Crohn disease
97	Ulcerative colitis
145	West syndrome
149	Hemiconvulsion hemiplegia epilepsy syndrome
202	Smith-Magenis syndrome

2

Setmelanotide 💬

[1] Setmelanotide

[1] Setmelanotide

[1] MC4R 💬

[3] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬

[4] 134, 193, 202, 265 💬

3

Setmelanotide acetate 💬

[1] Setmelanotide

[1] Setmelanotide

[1] MC4R 💬

[3] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬

[4] 134, 193, 202, 265 💬

4

Tasimelteon 💬

[1] Tasimelteon

[1] Tasimelteon

[2] MTNR1A,
MTNR1B 💬

[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬

[1] 202 💬